Product Description
Lyme Disease ImmuneSelect is a Immune Select peptide pool composed of 41 peptides that cover MHC-II restricted epitopes of Borrelia burgdorferi (Lyme Disease Borrelia). Peptide sequences are derived from: Borrelia P83/P100 antigen Histidine kinase Immunogenic protein P37 Outer surface protein A Outer surface protein C The purity of each peptide is 90% (HPLC-MS). The in vitro stimulation of Peripheral Blood Mononuclear Cells (PBMCs) with Lyme Disease ImmuneSelect Peptide Pool activates memory T cells specific to the infection, leading to cytokine secretion and the increased expression of specific surface markers.
* VAT and shipping costs not included. Errors and price changes excepted
